Capozzolo Alberto, Castellana Giorgio, Dragonieri Silvano, Carratù Pierluigi, Liotino Vito, Vulpi Maria Rosaria, Marra Lorenzo, Resta Emanuela, Intiglietta Pierluigi, Resta Onofrio
Department of Cardiac, Thoracic, and Vascular Science, Institute of Respiratory Disease, School of Medicine, University of Bari, Bari, Italy.
Int J Chron Obstruct Pulmon Dis. 2017 Jul 11;12:2035-2042. doi: 10.2147/COPD.S136357. eCollection 2017.
Underdiagnosis of COPD is a relevant issue, and most frequently involves patients at early stages of the disease. Physicians do not routinely recommend smokers to undergo spirometry, unless they are symptomatic.
To investigate the effectiveness of voluntary lung function screening in bringing to light patients with previously unknown COPD and to evaluate the relationships among symptoms, smoking status, and airway obstruction.
A voluntary screening study for COPD was conducted during two editions of the annual Fiera del Levante (2014 and 2015), an international trade fair in Bari. Subjects were eligible for the study if they fulfilled the following inclusion criteria: age ≥35 years, smoker/ex-smoker ≥5 pack-years (PYs), or at least one chronic respiratory symptom (cough, sputum production, shortness of breath, and wheezing). A free post-β-agonist spirometry test was performed by trained physicians for each participant using portable spirometers. Post-β-agonist forced expiratory volume in 1 second (FEV):forced vital capacity ratio <0.7 was chosen to establish the diagnosis of COPD. Sensitivity, specificity, and negative and positive predictive values (NPVs and PPVs) of symptoms for the presence of obstruction were calculated.
A total of 1,920 individuals were eligible for the study; 188 subjects (9.8%) met COPD criteria. There was a 10.4% prevalence of COPD in subjects with one or more symptoms who had never smoked or smoked ≤5 PYs. Among COPD patients, prevalence of symptoms increased in the presence of FEV <80%. COPD smokers were more symptomatic than smokers without COPD. Sensitivity and specificity in all subjects with one or more symptoms were 87% and 32%, respectively, whereas in smoker subgroups, sensitivity and specificity were 71% and 41% (≥5 PYs) and 74% and 35% (≥10 PYs), respectively. In all subjects, the presence of at least one symptom was associated with a low PPV for COPD of 11%, but a very high NPV (96%). These data did not change if the analysis was limited to smokers.
Voluntary public lung function screening programs in Italy are effective, and may detect a large number of undiagnosed subjects with COPD in early stages. In our population, COPD symptoms had low specificity and PPV, even considering smokers only.
慢性阻塞性肺疾病(COPD)诊断不足是一个重要问题,且最常涉及疾病早期阶段的患者。医生通常不会建议吸烟者进行肺功能测定,除非他们出现症状。
研究自愿性肺功能筛查在发现此前未知的COPD患者方面的有效性,并评估症状、吸烟状况和气道阻塞之间的关系。
在巴里举办的两届年度费拉德尔莱万特国际博览会(2014年和2015年)期间开展了一项COPD自愿筛查研究。符合以下纳入标准的受试者有资格参加本研究:年龄≥35岁,吸烟者/戒烟者吸烟量≥5包年(PYs),或至少有一种慢性呼吸道症状(咳嗽、咳痰、气短和喘息)。由经过培训的医生使用便携式肺功能仪为每位参与者进行一次β-受体激动剂后肺功能测定试验。采用β-受体激动剂后1秒用力呼气容积(FEV):用力肺活量比值<0.7来诊断COPD。计算症状对于存在阻塞的敏感性、特异性以及阴性和阳性预测值(NPVs和PPVs)。
共有1920人符合研究条件;188名受试者(9.8%)符合COPD标准。在从未吸烟或吸烟量≤5 PYs且有一项或多项症状的受试者中,COPD患病率为10.4%。在COPD患者中,FEV<80%时症状患病率增加。COPD吸烟者比无COPD的吸烟者症状更多。在所有有一项或多项症状的受试者中,敏感性和特异性分别为87%和32%,而在吸烟亚组中,敏感性和特异性分别为71%和41%(≥5 PYs)以及74%和35%(≥10 PYs)。在所有受试者中,至少有一种症状与COPD的低阳性预测值(PPV)11%相关,但阴性预测值(NPV)非常高(96%)。如果分析仅限于吸烟者,这些数据不会改变。
意大利的自愿性公众肺功能筛查项目是有效的,且可能检测出大量早期未被诊断的COPD患者。在我们的人群中,即使仅考虑吸烟者,COPD症状的特异性和PPV也较低。